Publications 2000-2011, members of staff
Books/Reports or Chapters in Books/Reports
Information & Statistics Division. Cancer. In: Scottish Health Statistics 1999. (pp 73-93) Edinburgh: ISD Scotland Publications, 2000.
Miñarro R, Black RJ, Martínez C, Navarro C, Garau I, Izarzugaza I, Ardanaz E, Vergara A, Galcerán J, Alonso R, Mateos A, Rodríguez M (eds). Cancer Incidence and Mortality in Spain. IARC Technical Report No. 36. Lyon: International Agency for Research on Cancer, 2000.
Scottish Cancer Intelligence Unit. Trends in Cancer Survival in Scotland 1971 - 1995. Edinburgh: Information & Statistics Division, 2000.
McCann J, Stockton D. Screening evaluation and monitoring: some practical considerations. In: Duffy S, Hill C, Estève J (eds). Cancer Screening – Methods of Quantitive Evaluation. London: Arnold Publishers, 2001, pp 81-92.
Scottish Executive Health Department. Cancer Scenarios: An aid to planning cancer services in Scotland in the next decade. Edinburgh: The Scottish Executive, 2001.
Stockton D, McCann J. Breast cancer-selected examples. In: Sankila R, Démaret E, Hakama M, Lynge E, Schouten L, Parkin DM (eds). Evaluation and Monitoring of Screening Programmes. Brussels-Luxembourg: European Commission, 2001, pp 181-194.
Stockton D. Cancer Survival in Scotland - Understanding Social Variations (PhD Thesis). London: London School of Hygiene and Tropical Medicine, 2001.
Brewster D, Harkness E, Harvey J, Kidd J, Black R. UK, Scotland. In: Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds). Cancer Incidence in Five Continents (volume VIII). IARC Scientific Publications No. 155. Lyon: International Agency for Research on Cancer, 2002.
Black R, Stockton D, Brewster D. Scenario planning using cancer incidence and mortality projections. In: Sankila R, Black R, Coebergh JW, Démaret E, Forman D, Gatta G, Parkin DM (eds). Evaluation of Clinical Care by Cancer Registries. (pp 47-50). IARC Technical Report No. 37. Lyon: International Agency for Research on Cancer, 2003.
Brewster D, Gregor A. Cancer in Scotland. In: Woods K, Carter D (eds). Scotland's Health and Health Services. Nuffield Trust for Research and Policy Studies in Health Services. London: The Stationery Office, 2003.
Sankila R, Black R, Coebergh JW, Démaret E, Forman D, Gatta G, Parkin DM (eds). Evaluation of Clinical Care by Cancer Registries. IARC Technical Publication No. 37. Lyon: International Agency for Research on Cancer, 2003.
Campbell J, Wallace WHB, Bhatti LA, Stockton DL, Rapson T, Brewster DH. Childhood Cancer in Scotland: Trends in Incidence, Mortality, and Survival, 1975-1999. Edinburgh: Information & Statistics Division, 2004.
Brewster D, Møller H. Larynx. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.
Møller H, Brewster D. Lip, mouth and pharynx. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.
Rowan S, Brewster D. Colorectal. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.
Wood H, Brewster D, Møller H. Oesophagus. In: Quinn M, Wood H, Cooper N, Rowan S (eds). Cancer Atlas of the United Kingdom and Ireland 1991-2000. ONS SMPS No. 68. Basingstoke: Palgrave MacMillan, 2005.
Brewster D, Bhatti L, McDonald A, Stark J, Black R. Cancer Incidence in Scotland (1998-2002). In: Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, Boyle P (eds). Cancer Incidence in Five Continents (volume IX). IARC Scientific Publications No. 160. Lyon: International Agency for Research on Cancer, 2007.
Papers and letters in journals
Brewster DH, Fraser LA, Harris V, Black RJ. Rising incidence of prostate cancer in Scotland: increased risk or increased detection? BJU Int 2000; 85: 463-472.
Brewster DH, Fraser LA, McKinney PA, Black RJ. Socioeconomic status and risk of adenocarcinoma of the oesophagus and cancer of the gastric cardia in Scotland. Br J Cancer 2000; 83: 387-390.
Cheng KK, Sharp L, McKinney PA, Logan RFA, Chilvers CED, Cook Mozaffari P, Ahmed A, Day NE. A case-control study of oesophageal adenocarcinoma in women: a preventable disease. Br J Cancer 2000; 83: 127-132.
Coleman MP, Babb P, Stockton D, Forman D, Moller H. Correspondence. Lancet 2000; 35: 590-591.
Coleman MP, Stockton D, Babb P, Richards M. Survival and reduction in mortality from breast cancer (letter). BMJ 2000; 321: 1471-1472.
Richards MA, Stockton D, Babb P, Coleman MP. How many deaths have been avoided through improvements in cancer survival? BMJ 2000; 320: 895-898.
The UK Childhood Cancer Study Investigators. Childhood Cancer and Residential Proximity to Power Lines. Br J Cancer 2000; 83: 1573-1580.
Thomas E, Brewster DH, Black RJ, Macfarlane GJ. The Risk of Malignancy Amongst Patients with Rheumatic Conditions. Int J Cancer 2000; 88: 497-502.
UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study: objectives, materials and methods. Br J Cancer 2000; 82: 1073-1102.
Brewster DH, Coleman MP, Forman D, Roche M. Cancer information under threat: the case for legislation. Ann Oncol 2001; 12: 145-147.
Brewster DH, Thomson CS, Hole DJ, Black RJ, Stroner PL, Gillis CR, on behalf of the Scottish Cancer Therapy Network. Relationship between socioeconomic status and tumour stage in breast, colorectal, ovarian, and lung cancer patients: results from four national, population-based studies. BMJ 2001; 322: 830-831.
Cull A, Gould A, House A, Smith A, Strong V, Velikova G, Wright P, Selby P. Validated automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice. Br J Cancer 2001; 85: 1842-1849.
Cull A, Howat S, Greimel E, Waldenstrom AC, Arraras J, Kudelka A, Chauvenet L, Gould A. EORTC Quality of Life Group [European Organization for Research and Treatment of Cancer]. Scottish Gynaecological Cancer Trials Group. Development of a European Organization for Research and Treatment of Cancer questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials: a progress report. Eur J Cancer 2001; 37: 47-53.
Forman D, Roche M, Coleman M, Brewster D. Monitoring of cancer risks and survival rates requires information on all cancer patients. Br J Healthcare Comput Info Manage 2001; 18: 24-26.
Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Management and survival of lung cancer patients diagnosed in 1995 in Scotland: results of a national, population-based study. Thorax 2001; 56: 212-217.
Howard GCW, Thomson CS, Stroner PL, Goodman CM, Windsor PM, Brewster DH. Patterns of referral, management and survival of patients diagnosed with prostate cancer in Scotland during 1988 and 1993: results of a national, retrospective population-based audit. BJU Int 2001; 87: 339-347.
Sharp L, Chilvers CED, Cheng KK, McKinney PA, Logan RFA, Cook-Mozaffari, Ahmed A, Day NE. Risk factors for squamous cell carcinoma of the oesophagus in women: a case-control study. Br J Cancer 2001; 85: 1667-1670.
Sorahan T, McKinney PA, Mann JR, Lancashire RJ, Stiller CA, Birch JM, Dodd HE, Cartwright RA. Childhood cancer and parental use of tobacco: findings from the inter-regional epidemiological study of childhood cancer (IRESCC). Br J Cancer 2001; 84: 141-146.
Stockton D, Doherty V, Brewster DH. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001; 85: 41-45.
Thomson CS, Hole DJ, Twelves C, Brewster DH, Black RJ. Prognostic factors in women with breast cancer: distribution by socio-economic status and effect on differences in survival. J Epidemiol Community Health 2001; 55: 308-315.
Twelves C, Thomson CS, Brewster DH, Dewar JA. Variation in survival of women with breast cancer: Health Board remains a factor at ten years. Br J Cancer 2001; 85: 637-640.
Wright EP, Selby PJ, Gould A, Cull A. Detecting social problems in cancer patients. Psycho-Oncol 2001; 10: 242-250.
Brewster DH, Stockton D, Harvey J, Mackay M. Reliability of cancer registration data in Scotland, 1997. Eur J Cancer 2002; 38: 414-417.
Erridge SC, Thomson CS, Davidson J, Jones RD, Price A, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Factors influencing the use of thoracic radiotherapy in lung cancer - an analysis of the 1995 Scottish lung cancer audit. Clin Oncol 2002; 14: 219-227.
Gray RF, Brewster DH, Kidd J, Burns H. Colorectal Cancer in Scotland: Recent Trends in Incidence and Mortality. Gastrointestinal Oncology 2002; 4: 213-222.
Harkness EF, Brewster DH, Kerr KM, Fergusson RJ, MacFarlane GJ. Changing trends in incidence of lung cancer by histological type in Scotland. Int J Cancer 2002; 102: 179-183.
Roman E, Fear NT, Ansell P, Bull D, Draper G, McKinney P, Michaelis J, Passmore SJ, von Kries R. Vitamin K and childhood cancer: analysis of individual patient data from six case-control studies. Br J Cancer 2002; 86: 63-69.
Smith AB, Selby PJ, Velikova G, Stark D, Wright EP, Gould A, Cull A. Factor analysis of the Hospital Anxiety and Depression Scale from a large cancer population.Psychology and Psychotherapy: Theory, Research and Practice 2002; 75: 165-176.
Thomson CS, Twelves CJ, Mallon EA, Leake RE. Adjuvant ovarian ablation vs CMF chemotherapy in premenopausal breast cancer patients: trial update and impact of immunohistochemical assessment of ER status. Breast2002; 11: 419-429.
UK Childhood Cancer Study Investigators (writing committee Law GR, Smith AG, Roman E). The importance of full participation: lessons from a national case-control study. Br J Cancer 2002; 86: 350-355.
UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 1: radon gas. Br J Cancer 2002; 86: 1721-1726.
UK Childhood Cancer Study Investigators. The United Kingdom Childhood Cancer Study of exposure to domestic sources of ionising radiation: 2: gamma radiation. Br J Cancer 2002; 86: 1727-1731.
Allardice GM, Hole D, Brewster D, Boyd J, Goldberg D. Incidence of malignant neoplasms among HIV infected persons in Scotland by HIV risk group. Br J Cancer 2003; 83: 505-507.
Anderson TJ, Davis C, Alexander FE, Dobson HM, on behalf of the Scottish Breast Pathology Coordination Group. Measures of benefit for breast screening from the pathology database for Scotland, 1991-2001. J Clin Pathol 2003; 56: 654-659.
Fergusson RJ, Thomson CS, Brewster DH, Brown PH, Milroy R, on behalf of the Scottish Cancer Trials Lung Group and the Scottish Cancer Therapy Network. Lung Cancer in Scotland - Importance of Seeing a Respiratory Physician. Eur Resp J 2003; 21: 606– 610.
Forman D, Stockton D, Møller H, Quinn M, Babb P, De Angelis R, Micheli A. Cancer prevalence in the UK: results from the EUROPREVAL Study. Ann Oncol 2003;14: 648– 654.
McKenna DB, Stockton D, Brewster DH, Doherty VR. Evidence for an Association between Cutaneous Malignant Melanoma and Lymphoid Malignancy: a Population-based Retrospective Cohort Study in Scotland. Br J Cancer 2003; 88: 74-78.
McKinney PA, Fear NT, and Stockton D, on behalf of the UK Childhood Cancer Study Investigators. Parental occupation at periconception: findings from the United Kingdom Childhood Cancer Study. Occup Environ Med 2003; 50: 901-909.
Micheli A, Coebergh JW, Mugno E, Massimiliani E, Sant M, Oberaigner W, Holub J, Storm HH, Forman D, Quinn M, Aareleid T, Sankila R, Hakulinen T, Faivre J, Ziegler H, Tryggvadòttir L, Zanetti R, Dalmas M, Visser O, Langmark F, Bielska-Lasota M, Wronkowski Z, Pinheiro PS, Brewster DH, Plesko I, Pompe-Kirn V, Martinez-Garcia C, Barlow L, Möller T, Lutz JM, André M, Steward JA. European health systems and cancer care. Ann Oncol 2003; 14 (supplement 5): v41-v60.
Pang D, McNally R, Birch JM on behalf of the UK Childhood Cancer Study Investigators. Parental smoking and childhood cancer: results from the United Kingdom Childhood Cancer Study. Br J Cancer 2003;88: 373-381.
Quinn MJ, d'Onofrio A, Møller B, Black R, Martinez-Garcia C, Møller H, Rahu M, Robertson C, Schouten LJ, La Vecchia C, Boyle P. Cancer mortality trends in the EU and acceding countries up to 2015. Ann Oncol 2003; 14: 1148-1152.
Salmon CA, Park KGM, Rapson T, Phull PS. Age threshold for endoscopy and the risk of missing upper GI malignancy: Data from the Scottish Audit of Gastric and Oesophageal Cancer. Gut 2003; 52: A26.
The Scottish/Northern Irish BRCA1/BRCA2 Consortium. BRCA1 and BRCA2 mutations in Scotland and Northern Ireland. Br J Cancer 2003; 88: 1256-1262.
Thomas E, Symmons DPM, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in Rheumatoid Arthritis, Juvenile Chronic Arthritis, and Other Rheumatic Conditions: a 20– year follow-up study. J Rheumatol 2003; 30: 958-965.
UK Coordinating Committee on Cancer Research (UKCCCR) Ductal Carcinoma in situ (DCIS) Working Party on behalf of DCIS trialists in the UK, Australia, and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial. Lancet 2003; 362: 95-102.
Willett EV, McKinney PA, Fear NT, Cartwright RA, Roman E. Occupational exposure to electromagnetic fields and acute leukaemia: analysis of a case-control study.Occup Environ Med 2003; 60: 577-583.
Wong NACS, Rae F, Herriot M, Mayer NJ, Brewster DH, Harrison DJ. SV40 Tag DNA sequences, present in a small proportion of human hepatocellular carcinomas, are associated with reduced survival. J Clin Pathol 2003; 56: 904-909.
Wong NACS, Young R, Malcomson RDG, Nayar AG, Jamieson L, Han C, Save VE, Carey F, Brewster D, Al-Nafussi A. Prognostic indicators for gastrointestinal stromal tumors: a clinicopathological and immunohistochemical study of 108 resected cases of the stomach. Histopathology 2003; 43: 118-126.
Wood R, Brewster DH, Fraser LA, Brown H, Hayes PC, Garden OJ. Do increases in mortality from intrahepatic cholangiocarcinoma reflect a genuine increase in risk? Insights from cancer registry data in Scotland. Eur J Cancer 2003; 39: 2087-2092.
Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968-1998. Eur J Cancer 2003; 39: 2080-2086.
Brewster DH, Fordyce A, Black RJ, and the Scottish Clinical Geneticists. Impact of a cancer registry-based genealogy service to support clinical genetics services. Fam Cancer 2004; 3: 139-141.
Clark AJ, Stockton D, Elder A, Wilson RG, Dunlop MG. Assessment of outcomes after colorectal cancer resection in the elderly as a rationale for screening and early detection. Br J Surgery 2004; 91: 1345-1351.
Leonard RC, Lind M, Twelves C, Coleman R, van Belle S, Wilson C, Ledermann J, Kennedy I, Barrett-Lee P, Perren T, Verrill M, Cameron D, Foster E, Yellowlees A, Crown J; Anglo-Celtic Cooperative Oncology Group. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial. J Natl Cancer Inst 2004; 96: 1076-1083.
McCallum M, Baker C, Gillespie K, Cohen B, Stewart H, Leonard R, Cameron D, Leake R, Paxton J, Robertson A, Purdie C, Gould A, Steel M. A prognostic index for operable, node-negative breast cancer. Br J Cancer 2004: 90; 1933-1941.
Mitchell RJ, Brewster D, Campbell H, Porteous MEM, Wyllie AH, Bird CC, Dunlop MG. Accuracy of reporting of family history of colorectal cancer. Gut 2004; 53: 291-295.
Mould R, Lahanas M, Asselain B, Brewster D, Burgers S, Damhuis R, De Rycke Y, Gennaro V, Szeszenia-Dabrowska N. Methodology for lognormal modelling of malignant pleural mesothelioma survival time distributions: a study of 5580 case histories from Europe and USA. Phys Med Biol 2004; 49: 3991-4004.
Murchison JT, Wylie L, Stockton DL. Excess risk of cancer in patients with primary venous thromboembolism: a national, population-based cohort study. Br J Cancer 2004; 91: 92-95.
Parks RW, Bettschart V, Frame S, Stockton DL, Brewster DH, Garden OJ. Benefits of specialisation in the management of pancreatic cancer: results of a Scottish population-based study. Br J Cancer 2004; 91: 459-465.
Stark C, Hopkins P, Gibbs D, Rapson T, Belbin A, Hay A. Trends in suicide in Scotland 1981 - 1999: age, method and geography. BMC Public Health 2004; 4: 49.
Thompson AM, Rapson T, Gilbert FJ, Park KG. Endoscopic palliative treatment for esophageal and gastric cancer: techniques, complications, and survival in a population-based cohort of 948 patients. Surg Endosc 2004; 18: 1257-1262.
Thomson CS, Brewster DH, Dewar JA, Twelves CJ on behalf of the Scottish Cancer Therapy Network. Improvement in survival for women with breast cancer in Scotland between 1987 and 1993: Impact of earlier diagnosis and changes in treatment. Eur J Cancer 2004; 40: 743-753.
Black R. Ensuring high-quality epidemiological data on cancer. Eur J Cancer Prev 2005; 14: 305-306.
Brennan P, Scélo G, Hemminki K, Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride ML, Kliewer EV, Tonita JM, Seow A, Pompe-Kirn V, Martos C, Jonasson JG, Colin D, Boffetta P. Second primary cancers among 109,000 cases of non-Hodgkin lymphoma. Br J Cancer 2005; 93: 159-166.
Brewster DH, Coebergh JW, Storm HH. Population-based cancer registries: the invisible key to cancer control. Lancet Oncol 2005; 6: 193-195.
Brewster DH, Stockton DL, Dobbie R, Bull D, Beral V. Risk of breast cancer following miscarriage or induced abortion: a Scottish record linkage case-control study. J Epidemiol Community Health 2005; 59: 283-287.
Evans TR, Yellowlees A, Foster E, Earl H, Cameron DA, Hutcheon AW, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Mansi JL. Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: an anglo-celtic cooperative oncology group study. J Clin Oncol 2005; 23: 2988-2995.
Hemminki K, Scelo G, Boffetta P, Mellemkjaer L, Tracey E, Andersen A, Brewster D, Pukkala E, McBride M, Kliewer E, Chia K-S, Pompe-Kirn V, Martos C, Jonasson J, Li X, Brennan P. Second primary malignancies in patients with male breast cancer. Br J Cancer 2005; 92: 1288-1292.
Mitchell RJ, Campbell H, Farrington SM, Brewster DH, Porteous ME, Dunlop MG. Prevalence of Family History of Colorectal Cancer in the General Population. Br J Surg 2005; 92: 1161-1164.
Murray CS, Stockton DL, Doherty VR. Thick melanoma: the challenge persists. Br J Dermatol 2005; 152: 104-109.
Nanthakumaran S, Fernandes E, Thompson AM, Rapson T, Gilbert FJ, Park KG. Morbidity and mortality rates following gastric cancer surgery and contiguous organ removal, a population based study. Eur J Surg Oncol 2005; 31: 1141-1144.
Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MWJ. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol 2005; 62: 156-162.
Storm H, Brewster DH, Coleman MP, Deapen D, Oshima A, Threlfall T, Démaret E. Guidelines for confidentiality and cancer registration (letter). Br J Cancer 2005; 92: 2095-2096.
Swerdlow AJ, Jones ME, for the British Tamoxifen Second Cancer Study Group. Tamoxifen treatment for breast cancer and risk of endometrial cancer: a case-control study. J Natl Cancer Inst 2005; 97: 375-384.
Brewster DH, Bhatti LA. Increasing incidence of squamous cell carcinoma of the anus in Scotland, 1975-2002. Br J Cancer 2006; 95: 87-90.
Camidge DR, Stockton DL, Bain M. Factors affecting the mesothelioma detection rate within national and international epidemiological studies: insights from Scottish linked cancer registry-mortality data. Br J Cancer 2006; 95: 649-652.
Conway DI, Stockton DL, Warnakulasuriya KAAS, Ogden G, Macpherson LMD. Incidence of oral and oropharyngeal cancer in United Kingdom (1990-1999) - recent trends and regional variation. Oral Oncol 2006; 42: 586-592.
Malinovszky KM, Gould A, Foster E, Cameron D, Humphreys A, Crown J, Leonard RC; Anglo Celtic Co-operative Oncology Group. Quality of life and sexual function after high-dose or conventional chemotherapy for high-risk breast cancer. Br J Cancer 2006; 95: 1626-1631.
Mellemkjær L, Friis S, Olsen JH, Scélo G, Hemminki K, Tracey E, Andersen A, Brewster DH, Pukkala E, McBride M, Kliewer EV, Tonita JM, Kee-Seng C, Pompe-Kirn V, Martos C, Jonasson JG, Boffetta P, Brennan P. Risk of second cancer among women with breast cancer. Int J Cancer 2006; 118: 2285-2292.
Phull PS, Salmon CA, Park KG, Rapson T, Thompson AM, Gilbert FJ. Age threshold for endoscopy and risk of missing upper gastrointestinal malignancy - data from the Scottish audit of gastric and oesophageal cancer. Aliment Pharmacol Ther 2006; 23: 229-233.
Poole CJ, Earl HM, Hiller L, Dunn JA, Bathers S, Grieve RJ, Spooner DA, Agrawal RK, Fernando IN, Brunt AM, O'Reilly SM, Crawford SM, Rea DW, Simmonds P, Mansi JL, Stanley A, Harvey P, McAdam K, Foster L, Leonard RC, Twelves CJ; NEAT Investigators and the SCTBG. Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer. N Engl J Med 2006; 355: 1851-1862.
Reis MM, Young D, McLeish L, Goudie D, Cook A, Sullivan F, Vysny H, Fordyce A, Black R, Tavakoli M, Steel M. Analysis of referrals to a multi-disciplinary breast cancer genetics clinic: practical and economic considerations. Fam Cancer 2006; 5: 297-303.
Sandeep TC, Strachan MWJ, Reynolds RM, Brewster DH, Scélo G, Pukkala E, Hemminki K, Andersen A, Tracey E, Friis S, McBride ML, Kee-Seng C, Pompe-Kirn V, Kliewer EV, Tonita JM, Jonasson JG, Martos C, Boffetta P, Brennan P. Second primary cancers in thyroid cancer patients: a multi-national record linkage study. J Clin Endocrinol Metab 2006; 91: 1819-1825.
Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Andersen A, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Colin D, Brennan P. Associations between small intestine cancer and other primary cancers: An international population-based study. Int J Cancer 2006; 118: 89-96.
Shack LG, Wood HE, Kang JY, Brewster DH, Quinn MJ, Maxwell JD, Majeed A. Small intestinal cancer in England & Wales and Scotland: Time trends in incidence, mortality and survival. Aliment Pharmacol Ther 2006; 23: 1297-1306.
Shen M, Boffetta P, Olsen JH, Andersen A, Hemminki K, Pukkala E, Tracey E, Brewster DH, McBride ML, Pompe-Kirn V, Kliewer EV, Tonita JM, Chia K-S, Martos C, Jonasson JG, Colin D, Scélo G, Brennan P. A Pooled Analysis of Second Primary Pancreatic Cancer. Am J Epidemiol 2006; 163: 502-511.
Brewster DH, Bhatti LA, Inglis JHC, Nairn ER, Doherty VR. Recent trends in incidence of non-melanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol 2007; 156: 1295-1300.
Brewster DH, Horner M-JD, Rowan S, Jelfs P, de Vries E, Pukkala E. Left-sided excess of invasive cutaneous melanoma in six countries. Eur J Cancer 2007; 43: 2634-2637.
Camidge DR, Stockton DL, Frame S, Wood R, Bain M, Bateman DN. Hospital admissions and deaths relating to deliberate self-harm and accidents within 5 years of a cancer diagnosis: a national study in Scotland, UK. Br J Cancer 2007; 96: 752-757.
Conway DI, Brewster DH, McKinney PA, Stark J, McMahon AD, Macpherson LMD. Widening socio-economic inequalities in oral cancer incidence in Scotland, 1976-2002. Br J Cancer 2007; 96: 818-820.
Engholm G, Kejs AMT, Brewster DH, Gaard M, Holmberg L, Hartley R, Iddenden R, Møller H, Sankila R, Thomson CS, Storm HH. Colorectal cancer survival in the Nordic countries and the UK. Excess mortality risk analysis of 5-year relative period survival in the period 1999-2000. Int J Cancer 2007; 121: 1115-1122.
Erridge SC, Featherstone C, Chalmers R, Campbell J, Stockton D, Black R. What will be the radiotherapy machine capacity required for optimal delivery of radiotherapy in Scotland in 2015? Eur J Cancer 2007; 43: 1802-1809.
Erridge SC, Moller H, Price A, Brewster D. International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 2007; 4: 570-577.
Maule M, Scélo G, Merletti F, Brennan P, Hemminki K, Tracey E, Sankila R, Weiderpass Vainio E, Olsen JH, McBride ML, Brewster DH, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Pastore G, Boffetta P. Risk of second malignant neoplasms after childhood leukemia and lymphoma: an international study. J Natl Cancer Inst 2007; 99: 790-800.
Mowbray M, Stockton DL, Doherty VR. Changes in the site distribution of malignant melanoma in South East Scotland (1979-2002). Br J Cancer 2007; 96: 832-835.
Richiardi L, Scélo G, Boffetta P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Kee-Seng C, Jonasson JG, Martos C, Brennan P. Second malignancies among survivors of germ-cell testicular cancer: a pooled analysis between 13 Cancer Registries. Int J Cancer 2007; 120: 623-631.
Riska A, Pukkala E, Scélo G, Mellemkjaer L, Hemminki K, Weiderpass E, McBride ML, Pompe-Kirn V, Tracey E, Brewster DH, Kliewer EV, Tonita JM, Kee-Seng C, Jonasson JG, Martos C, Boffetta P, Brennan P. Second primary malignancies in females with primary fallopian tube cancer. Int J Cancer 2007; 120: 2047-2051.
Scélo G, Boffetta P, Autier A, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Giblin M, Brennan P. Associations between ocular melanoma and other primary cancers: an international population-based study. Int J Cancer 2007; 120: 152-159.
Scélo G, Boffetta P, Corbex M, Chia K-S, Hemminki K, Friis S, Pukkala E, Weiderpass E, McBride ML, Tracey E, Brewster DH, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Brennan P. Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control 2007; 18: 269-278.
Shack LG, Rachet B, Brewster DH, Coleman M. Socioeconomic inequalities in cancer survival in Scotland 1986-2000. Br J Cancer 2007; 97: 999-1004.
Stark JM, Black RJ, Brewster DH. Risk of leukaemia among children living near the Solway coast of Dumfries and Galloway Health Board area, Scotland, 1975-2002. Occup Environ Med 2007; 64: 66-68.
Thompson AM, Rapson T, Gilbert FJ, Park KG; Scottish Audit of Gastric and Oesophageal Cancer. Hospital volume does not influence long-term survival of patients undergoing surgery for oesophageal or gastric cancer. Br J Surg 2007; 94: 578-584.
Tuohimaa P, Pukkala E, Scélo G, Olsen JH, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Kliewer EV, Pompe-Kirn V, McBride ML, Martos C, Chia K-S, Tonita JM, Jonasson JG, Boffetta P, Brennan P. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation. Eur J Cancer 2007; 43: 1701-1712.
Wild SH, Bryden JR, Lee RJ, Bishop JL, Finlayson AR, Byrne CD, Brewster DH. Cancer, cardiovascular disease and diabetes mortality among women with a history of endometrial cancer. Br J Cancer 2007; 96: 1747-1749.
Anandan C, Elton R, Hitchings A, Brewster DH. Nasopharyngeal Cancer Incidence and Survival in Scotland, 1975-2001. Clin Otolaryngol 2008; 33: 12-17.
Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Carnaghan H, Cetnarkyj R, Drummond S, Davidson R, Dunlop J, Fordyce A, Gibbons B, Goudie D, Gregory H, Holloway S, Longmuir M, McLeish L, Murday V, Miedzybrodska Z, Nicholson D, Pearson P, Porteous M, Reis M, Slater S, Smith K, Smyth E, Snadden L, Steel M, Stirling D, Watt C, Whyte C, Young D. Prospective surveillance of women with a family history of breast cancer: auditing the risk threshold. Br J Cancer 2008; 98: 840-844.
Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Cetnarskyj R, Drummond S, Davidson R, Dunlop J, Fordyce A, Gibbons B, Goudie D, Gregory H, Hanning K, Holloway S, Longmuir M, McLeish L, Murday V, Miedzybrodska Z, Nicholson D, Pearson P, Porteous M, Reis M, Slater S, Smith K, Smyth E, Snadden L, Steel M, Stirling D, Watt C, Whyte C, Young D. Predicting breast cancer risk: implications of a "weak" family history. Fam Cancer 2008; 7: 361-366.
Brewster DH, Stockton DL. Ascertainment of breast cancer by the Scottish Cancer Registry: An assessment based on comparison with five independent breast cancer trials databases. Breast 2008; 17: 106-108.
Brewster DH, de Vries E. Left-Sided Excess in the Laterality of Cutaneous Melanoma (letter). Arch Dermatol 2008; 144: 1235.
Chuang S-C, Hashibe M, Scélo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia K-S, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P. Risk of Second Primary Cancer among Esophageal Cancer Patients: a Pooled Analysis of 13 Cancer Registries. Cancer Epidemiol Biomarkers Prev 2008; 17: 1543-1549.
Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M. Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries. Int J Cancer 2008; 123: 2390-2396.
Erridge SC, Murray B, Price A, Ironside J, Little F, Mackean M, Walker W, Brewster DH, Black R, Fergusson RJ. Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol 2008;3: 491-498.
Gondos A, Bray F, Brewster DH, Coebergh JWW, Hakulinen T, Janssen-Heijnen MLG, Kurtinaitis J, Brenner H and the EUNICE Survival Working Group. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer 2008; 44: 1463-1475.
Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Pukkala E, Weiderpass E, Olsen JH, Tracey E, McBride ML, Brewster DH, Pompe-Kirn V, Tonita JM, Kliewer EV, Chia KS, Jonasson JG, Martos C, Magnani C, Boffetta P. Risk of second malignant neoplasms after childhood central nervous system malignant tumours: an international study. Eur J Cancer 2008; 44: 830-839.
Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009; 101 Suppl 2: S115-S124.
Brewster DH, Sharpe KH, Clark DI, Collins J. Declining breast cancer incidence and decreased HRT use (letter). Lancet 2009; 373: 459-460.
Erridge SC, Murray B, Williams L, Brewster D, Black R, Price A, Murray N, Sheehan F. Improved survival from lung cancer in British Columbia compared to Scotland – are different treatment rates the whole story? Lung Cancer 2009; 64: 358-366.
Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, Grant R, Kerr GR, Gregor A. Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother Oncol 2009; 93: 597-601.
Folkesson J, Engholm G, Ehrnrooth E, Kejs AMT, Påhlman L, Harling H, Wibe A, Gaard M, Jónsson P, Tryggvadottir L, Brewster DH, Hakulinen T, Storm HH. Rectal Cancer Survival in the Nordic Countries and Scotland. Int J Cancer 2009; 125: 2406-12.
Gondos A, Holleczek B, Janssen-Heijnen M, Brewster DH, Bray F, Rosso S, Hakulinen T, Brenner H and the EUNICE Survival Working Group. Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. Int J Cancer 2009; 125: 2666-72.
Jones A, Stockton DL, Simpson AJ, Murchison JT. Idiopathic venous thromboembolic disease is associated with a poorer prognosis from subsequent malignancy. Br J Cancer 2009; 101: 840-842.
Maddams J, Brewster D, Gavin A, Steward J, Elliott J, Utley M, Møller H. Cancer prevalence in the United Kingdom: estimates for 2008. Br J Cancer 2009; 101: 541-547.
Steele RJ, McClements PL, Libby G, Black R, Morton C, Birrell J, Mowat NA, Wilson JA, Kenicer M, Carey FA, Fraser CG. Results from the first three rounds of the Scottish demonstration pilot of FOBT screening for colorectal cancer. Gut 2009; 58: 530-535.
Bhopal R, Fischbacher C, Povey C, Chalmers J, Mueller G, Steiner M, Brown H, Brewster DH, Bansal N. Cohort profile: Scottish Health and Ethnicity Linkage Study of 4.65 million people exploring ethnic variations in disease in Scotland. Int J Epidemiol 2010 Jul 24. [Epub ahead of print]
Brewster DH, Tucker JS, Fleming M, Morris C, Stockton DL, Lloyd DJ, Bhattacharya S, Chalmers JWT. Risk of Skin Cancer after Phototherapy for Neonatal Jaundice: Retrospective Cohort Study. Arch Dis Child 2010; 95: 826-831.
Brewster DH, Black RJ. Survival is multifactorial (letter). BMJ 2010; 341: c5133.
Chuang SC, Scélo G, Lee YC, Friis S, Pukkala E, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Tamaro S, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Boffetta P, Brennan P, Hashibe M. Risks of second primary cancer among patients with major histological types of lung cancers in both men and women. Br J Cancer 2010; 102: 1190-1195.
Conway DI, McMahon AD, Smith K, Black R, Robertson G, Devine J, McKinney PA. Components of socioeconomic risk associated with head and neck cancer: a population-based case-control study in Scotland. Br J Oral Maxillofac Surg 2010; 48: 11-17.
Cuschieri K, Brewster DH, Williams AR, Millan D, Murray G, Nicoll S, Imrie J, Hardie A, Graham C, Cubie HA. Distribution of HPV types associated with cervical cancers in Scotland and implications for the impact of HPV vaccines. Br J Cancer 2010; 102: 930-932.
Doherty VR, Brewster DH, Jensen S, Gorman D. Trends in skin cancer incidence by socioeconomic position in Scotland, 1978-2004. Br J Cancer 2010; 102: 1661-1664.
Janssen-Heijnen MLG, Gondos A, Bray F, Hakulinen T, Brewster DH, Brenner H, Coebergh JWW. Clinical Relevance of Conditional Survival of Cancer Patients in Europe: Age-Specific Analyses of 13 Cancers. J Clin Oncol 2010; 28: 2520-2528.
Junor EJ, Kerr GR, Brewster DH. Oropharyngeal cancer. Fastest increasing cancer in Scotland, especially in men (letter). BMJ 2010; 340:c2512.
Lawder R, Harding O, Stockton D, Fischbacher C, Brewster DH, Chalmers J, Finlayson A, Conway DI. Is the Scottish population living dangerously? Prevalence of multiple risk factors: the Scottish Health Survey 2003. BMC Public Health 2010 Jun 11; 10: 330.
Mansi JL, Yellowlees A, Lipscombe J, Earl HM, Cameron DA, Coleman RE, Perren T, Gallagher CJ, Quigley M, Crown J, Jones AL, Highley M, Leonard RC, Evans TR. Five-year outcome for women randomised in a phase III trial comparing doxorubicin and cyclophosphamide with doxorubicin and docetaxel as primary medical therapy in early breast cancer: an Anglo-Celtic Cooperative Oncology Group study. Breast Cancer Res Treat 2010; 122: 787-94.
Rosso S, Gondos A, Zanetti R, Bray F, Zakelj M, Zagar T, Smailyte G, Ponti A, Brewster DH, Voogd AC, Crocetti E, Brenner H; the EUNICE Survival Working Group. Up-to-date estimates of breast cancer survival for the years 2000-2004 in 11 European countries: The role of screening and a comparison with data from the United States. Eur J Cancer 2010; 46: 3351-7.
Sharpe KH, McClements P, Clark DI, Collins J, Springbett A, Brewster DH. Reduced risk of oestrogen receptor positive breast cancer among peri- and post-menopausal women in Scotland following a striking decrease in use of hormone replacement therapy. Eur J Cancer 2010; 46: 937-943.
Skipworth RJE, Parks RW, Stephens NA, Graham C, Brewster DH, Garden OJ, Paterson-Brown S. The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003. Eur J Surg Oncol 2010; 36: 141-147.
Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C. Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen 2010; 17: 68-74.
Steele RJ, Kostourou I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C. Effect of repeated invitations on uptake of colorectal cancer screening using faecal occult blood testing: analysis of prevalence and incidence screening. BMJ 2010; 341: c5531.
Woods LM, Rachet B, Shack L, Catney D, Walsh PM, Cooper N, White C, Mak V, Steward J, Comber H, Gavin A, Brewster D, Quinn M, Coleman MP. Survival from twenty adult cancers in the UK and Republic of Ireland in the late twentieth century. Health Stat Q 2010; 46: 7-26.
Bosetti C, Scelo G, Chuang SC, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Olsen JH, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Brennan P, Hashibe M, Levi F, La Vecchia C, Boffetta P. High constant incidence rates of second primary cancers of the head and neck: A pooled analysis of 13 cancer registries. Int J Cancer 2011; 129: 173-9.
Brewster DH, Clark DI, Stockton DL, Munro AJ, Steele RJ. Characteristics of patients dying within 30 days of diagnosis of breast or colorectal cancer in Scotland, 2003-2007. Br J Cancer 2011; 104: 60-67.
Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Olsen JH, Tracey E, Pukkala E, Weiderpass E, Brewster DH, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Merletti F, Boffetta P. Second malignancies after childhood non-central nervous system solid cancer: Results from 13 cancer registries. Int J Cancer 2011 Apr 25. doi: 10.1002/ijc.26135. [Epub ahead of print]
Oliphant R, Brewster DH, Morrison DS. The changing association between socioeconomic circumstances and the incidence of colorectal cancer: a population-based study. Br J Cancer 2011; 104: 1791-6.